What is healthspan, and why isn't it the same as lifespan?

Most people, asked whether they want to live longer, hesitate. Asked whether they want to stay healthy longer, they don't. That instinct is the difference between lifespan and healthspan, and it turns out to be one of the more useful distinctions in population health.

The gap between living and living well

Lifespan is simple: the number of years between birth and death. Healthspan is the number of those years lived in good health — without significant chronic disease, disability, or functional limitation. The two are obviously related, but they are not the same measurement, and the space between them is large.

According to WHO estimates, the global gap between life expectancy and healthy life expectancy sits at roughly a decade. In high-income countries, where people live longer overall, the gap tends to be similar or slightly wider in absolute terms. That means the average person can expect somewhere around eight to twelve years at the end of life characterised by meaningful illness or loss of function.

This is not a rounding error. It's a substantial fraction of adult life, and it is the part of life that most medical spending, most caregiving, and most personal suffering concentrates into. It's also the part that lifestyle factors appear to influence most.

How healthspan is actually measured

"Healthspan" is a popular term rather than a precise clinical one, which is part of why it gets used loosely. The rigorous versions are these:

The Helixspan model anchors on HALE, because it is the measure with the most consistent international data behind it and because it maps most directly onto the intuitive question — how many good years are left. But it's worth knowing that all four measures give somewhat different answers, and that any single healthspan figure is a simplification of a genuinely contested measurement problem.

Compression of morbidity: the argument that started this

The intellectual origin of healthspan as a goal is a 1980 paper by the physician James Fries, who proposed what he called the compression of morbidity hypothesis. His argument ran roughly as follows: if the human lifespan has a relatively fixed biological ceiling, but the onset of chronic disease can be pushed later through prevention, then the period of illness at the end of life should get shorter. Ideally, you would live a long, healthy life and decline rapidly at the very end — a short, steep drop rather than a long, slow slide.

The competing prediction is expansion of morbidity: medicine gets better at keeping people alive with chronic disease without preventing the disease, so the sick period gets longer rather than shorter. People survive heart attacks, live with diabetes for decades, and accumulate conditions.

The evidence since 1980 is genuinely mixed, and honest summaries acknowledge that. Some cohorts show compression for some conditions; others show the ill period lengthening. What is clearer is that the two outcomes are not fixed by fate — the trajectory differs substantially between populations and between individuals with different risk profiles. That is the practical takeaway, and it is what makes prevention worth caring about even in the absence of a settled answer.

Why chronic illness concentrates at the end

The clustering of disease into late life isn't coincidence. Several mechanisms push in the same direction:

• Cumulative exposure. Many diseases are the product of decades of accumulated damage — arterial plaque, cellular mutation, joint wear. The exposure is gradual; the diagnosis is sudden.
• Declining reserve. Organ systems have spare capacity that erodes with age. A stress that a 30-year-old absorbs without noticing can tip a 75-year-old into failure.
• Multimorbidity compounding. Conditions rarely arrive alone, and each one makes the others harder to manage. The functional cost of three moderate conditions typically exceeds the sum of their individual costs.
• Competing risks resolve. Having avoided the causes of early death, you arrive in the age band where the slow degenerative diseases dominate.

The useful implication: the interventions that matter for healthspan mostly act on the accumulation phase, which is decades before anything shows up as symptoms. This is why lifestyle factors in your thirties and forties appear in cohort data as differences in outcomes in your seventies.

Why lifespan and healthspan can move in opposite directions

A counterintuitive but important point: an intervention can extend lifespan while shortening healthspan, or vice versa. Medical treatment that keeps someone alive through advanced illness extends lifespan and, depending on the illness, may extend the unhealthy portion. Prevention that delays disease onset extends healthspan and may or may not extend total lifespan much.

This is why the Helixspan model treats the two differently. Lifestyle modifiers move the healthspan estimate roughly point-for-point, but the lifespan estimate moves by a smaller factor — because unhealthy years still count as years lived. Somebody with poor lifestyle inputs doesn't simply die earlier; in the model, as in the data, they tend to spend more of their final years in poor health.

What actually moves healthspan

Large cohort studies converge on a fairly short list of behavioural factors that account for a substantial spread in healthy years. The most cited estimate, from Li and colleagues in Circulation in 2018, found that a combination of five low-risk lifestyle factors — not smoking, a healthy BMI, regular physical activity, moderate alcohol intake, and a high-quality diet — was associated with roughly twelve to fourteen additional years of life expectancy at age 50 in a US cohort.

Two cautions about that figure, both important. First, it is associational: these are observational cohorts, not randomised trials, and people who maintain five healthy habits differ from those who don't in ways that are hard to fully adjust for. Second, it is a population average, not a personal forecast. The number describes the difference between groups, not what any individual should expect.

Still, the direction and rough magnitude are consistent enough across independent cohorts, populations, and methodologies that the underlying claim — that behaviour accounts for a meaningful multi-year spread in healthy life — is on solid ground even if any specific number isn't.

What a healthspan number cannot tell you

The Helixspan score is a comparative readout built from seven inputs. Here is what it structurally cannot capture:

• Genetics. Heritable risk for cardiovascular disease, cancer, and neurodegenerative conditions varies enormously between individuals and is entirely absent from the model.
• Medical history and medication. An existing diagnosis, or effective treatment of one, changes the picture more than any lifestyle factor here.
• Access and circumstance. Income, healthcare access, air quality, occupational exposure, and social connection all show strong associations with healthy life expectancy. None are inputs.
• Interaction effects. The model adds factors independently. Real risk factors interact, and the combined effect isn't reliably the sum.
• Luck. Accident and infection are indifferent to your diet.

What the score is genuinely useful for is relative comparison: seeing which of your own modifiable inputs is costing you the most, and how much a change in one of them plausibly shifts the picture. Read as a rough map of where your leverage is, it's informative. Read as a prediction of your own future, it isn't — and no seven-input model could be.

If you want to see how each factor is weighted and why, the methodology section lays out every number the model uses. The guides below go through the factors one at a time.